Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as an Adjuvant Treatment in Endometrial Carcinoma
Conditions: Endometrial Carcinoma Interventions: Drug: Paclitaxel/epirubcin/carboplatin; Drug: Paclitaxel/carboplatin Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Conditions: Colorectal Cancer; Endometrial Cancer; Hereditary Cancer Syndromes Sponsors: Weill Medical College of Cornell University; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
Conditions: Endometrial Cancer Interventions: Genetic: low-depth whole-genome sequencing technology Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Nanjing Geneseeq Technology Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
Conditions: Endometrial Cancer; Atypical Hyperplasia Interventions: Drug: Ozempic; Drug: Mirena Sponsors: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
A Phase II Trial of Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Conditions: Endometrial Cancer; Endometrial Adenocarcinoma Interventions: Drug: Cadonilimab; Drug: Carboplatin; Drug: Cisplatin; Drug: Paclitaxel Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Conditions: Endometrial Cancer; Endometrial Adenocarcinoma Interventions: Drug: Cadonilimab; Drug: Carboplatin; Drug: Cisplatin; Drug: Paclitaxel Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer
Conditions: Ovarian Cancer; High Grade Serous Adenocarcinoma of Ovary; High Grade Endometrioid Ovarian Cancer; Primary Peritoneal Cancer; Fallopian-tube Cancer Interventions: Drug: Fluzoparib Capsules; Drug: Bevacizumab Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Iron Prehabilitation in Endometrial Cancer
Conditions: Endometrial Cancer; Perioperative Complication; Prehabilitation Intervention: Drug: Ferrous Gluconate 300 MG Sponsor: National and Kapodistrian University of Athens Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Iron Prehabilitation in Endometrial Cancer
Conditions: Endometrial Cancer; Perioperative Complication; Prehabilitation Interventions: Drug: Ferrous Gluconate 300 MG Sponsors: National and Kapodistrian University of Athens Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
